Actively Recruiting

Phase 4
Age: 18Years - 54Years
All Genders
NCT07166939

45th Multicenter Airway Research Collaboration

Led by Massachusetts General Hospital · Updated on 2026-04-17

1860

Participants Needed

1

Research Sites

81 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The study is a randomized controlled trial on the effect of emergency department initiation of Airsupra on acute asthma "recurrence" at 3 months and other related outcomes (acute asthma relapse, asthma control).

CONDITIONS

Official Title

45th Multicenter Airway Research Collaboration

Who Can Participate

Age: 18Years - 54Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Acute asthma diagnosis
  • Age between 18.0 and 54.9 years
  • English and/or Spanish speaking
  • Decision by ED doctor to discharge patient home with a short course of systemic corticosteroids
  • Willingness to use Airsupra as rescue inhaler for next 3 months (intervention group only)
  • Ability to properly use a metered-dose inhaler
  • Provided informed consent before any study procedures
Not Eligible

You will not qualify if you...

  • Involvement in planning or conducting this study
  • Previous enrollment in this study
  • Prior diagnosis of COPD, chronic bronchitis, or emphysema
  • Use of systemic corticosteroids in past 2 weeks
  • Participation in another investigational study within the past 4 weeks or 3 months after enrollment
  • Concurrent pneumonia
  • Clinically significant heart disease or cancer
  • Known allergy to Airsupra, albuterol sulfate, budesonide, or any product ingredients
  • For women: currently pregnant or breastfeeding
  • Sexually active women of childbearing age not using adequate contraception recently or planning to use it
  • Lack of working cell phone and email
  • Expected unavailability for follow-up by text or phone at 3, 6, and 12 weeks
  • Unable to provide an alternate contact with working phone and email

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

MetroHealth

Cleveland, Ohio, United States, 44109

Actively Recruiting

Loading map...

Research Team

C

Carlos A Camargo, MD, DrPH

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here